Gut microbiome and atrial fibrillation-results from a large population-based studyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This large population study asked whether gut microbiome composition is associated with atrial fibrillation. Researchers examined both prevalent atrial fibrillation and new incident cases over long follow-up. Stool underwent shallow shotgun metagenomic sequencing, mapped to taxonomy and functional gene groups. Findings were replicated in an independent case-control cohort. Analyses adjusted for age, sex, body mass index, blood pressure, smoking, alcohol, diabetes, heart failure, and cholesterol.
Who was studied?
The main sample was 6763 individuals from the FINRISK 2002 study, a random population sample of Finnish adults aged 25 to 74. It included 116 prevalent atrial fibrillation cases at baseline. Over a median follow-up of about 14.8 years, 539 individuals developed atrial fibrillation. Replication used an independent case-control cohort in Hamburg, Germany, of 138 individuals, 64 with an atrial fibrillation diagnosis.
What were the most important findings?
Prevalent atrial fibrillation was associated with nine microbial genera and incident atrial fibrillation with eight genera, at FDR-corrected P below 0.05. Both prevalent and incident disease were associated with the genera Enorma and Bifidobacterium, at FDR-corrected P below 0.001. Gut microbiome alpha and beta diversity were not significantly associated with atrial fibrillation. In the replication cohort, 75% of top genera, including Enorma, Paraprevotella, Odoribacter, Collinsella, Barnesiella, and Alistipes, shifted in a consistent direction.
What are the greatest implications of this study?
The results suggest specific gut genera, rather than overall diversity, relate to atrial fibrillation risk and could inform future risk prediction. The bacterial shift resembled patterns reported in hypertension and heart failure, hinting at shared pathophysiology. This raises the possibility that diet, probiotics, or other microbiome-directed steps might one day support prevention. The authors stress the associations are hypothesis-generating. Microbiome was measured once, and much more research is needed before use in prevention or treatment.